Menu

Intel and Asus: Letting AI Fly Can Save Lives

Intel and Asus. Letting AI Fly Can Save Lives

The News: Intel and ASUS announced in a recent blog post that ASUS is using Intel’s 11th Generation Intel Core Processor to power its ASUS EndoAIM Endoscopy System, which assists gastroenterologists and gastrointestinal surgeons in identifying and classifying real-time colonoscopy images leveraging AI. Read the Intel blog post for more information.

Intel and Asus: Letting AI Fly Can Save Lives

Intel and Asus
Image Source: Intel

Analyst Take: A key market for AI-based solutions is the business-to-business (B2B) sector, where working professionals are leveraging AI to augment their job functions as an extra guide, which is key for critical areas such as medical diagnostics that can mean life or death. To help healthcare organizations speed up and improve their diagnostic care, ASUS is leveraging the Intel 11th Generation Intel Core Processor to power its ASUS EndoAIM Endoscopy Systems, which help diagnostic professionals discern between polyps that are areas of concern versus those that are not.

The Market for AI-based Medical Diagnostics

The market for AI-based medical diagnostics is on the rise and is projected to grow north of a 20% compound annual growth rate (CAGR) over the next several years. The following are key catalysts for AI-based medical diagnostics.

  • Aging Populations: Growth of aging populations that represent significant portions of populations in North America, Asia Pacific, and EMEA.
  • Reducing Miss Rates: Augment the radiologist in identifying potential areas of concern that can sometimes be missed. In fact, AI-assisted colonoscopies reduce the miss rate by 50%. Thus, AI-infused medical devices can also be part of the organization’s risk mitigation strategy.
  • Margin Accretion Strategy: Radiology is one of the highest-margin departments of the hospital. Therefore, it also behooves management teams at the hospital to adopt AI-infused solutions that will help accelerate traffic.

Intel and Asus Collaboration

To help ASUS come up with an optimal solution for its clients, both Intel and ASUS collaborated and decided to come up with a smaller form factor to conserve space coupled with using the Intel 11th Generation CPU featuring Intel Iris X graphics.

The ASUS EndoAIM Endoscopy System helps diagnostic professionals discern between polyps that are areas of concern by classifying abnormalities by taking out the guesswork. To help ASUS fine-tune the ASUS EndoAIM Endoscopy device to find those abnormalities, Intel engineers leveraged its OpenVINO open-source software toolkit to quickly develop code to accelerate the development of the ASUS EndoAIM Endoscopy device.

This is an excellent win and use case for Intel, ASUS, and AI since the ASUS EndoAIM Endoscopy device will augment diagnostic teams and undoubtedly save lives in the future since AI-assisted colonoscopies reduce the miss rate by 50%.
Disclosure: The Futurum Group is a research and advisory firm that engages or has engaged in research, analysis, and advisory services with many technology companies, including those mentioned in this article. The author does not hold any equity positions with any company mentioned in this article.

Analysis and opinions expressed herein are specific to the analyst individually and data and other information that might have been provided for validation, not those of The Futurum Group as a whole.

Other insights from Futurum Research:

5G Factor: Chips Ahoy! How Chips are Integral to 5G Transformation with Qualcomm Promoting 5G Standalone, Juniper Beyond Labs Using Intel Xeon/FlexRAN, and Samsung MediaTek Boosting 3Tx Antennas 

Intel x86 Architecture: Architectural Consistency – The Best Assurance in Avoiding Costly New Support Structures 

Intel Meteor Lake: Placing Bets on On-Device AI 

Image Credit: Intel
Related Insights
Is Autonomous IT the Endgame for AI in Operations or Just the Start of a Bigger Shift?
April 12, 2026

Is Autonomous IT the Endgame for AI in Operations or Just the Start of a Bigger Shift?

As Autonomous IT evolves, CIOs must weigh efficiency gains against vendor lock-in and skills gaps, raising the question: is this AI's operational endgame or just the beginning?...
OpenAI’s GPT-5.3 Instant Mini: Does Faster AI Mean Smarter Enterprise Decisions?
April 12, 2026

OpenAI’s GPT-5.3 Instant Mini: Does Faster AI Mean Smarter Enterprise Decisions?

OpenAI's GPT-5.3 Instant Mini launch signals a critical shift in enterprise AI adoption. With 67% of organizations running GenAI in production and 75% increasing budgets, speed and cost-efficiency now drive...
OpenAI Sora Discontinuation: What the End of a Platform Means for Enterprise AI Strategy
April 12, 2026

OpenAI Sora Discontinuation: What the End of a Platform Means for Enterprise AI Strategy

OpenAI's 2026 Sora discontinuation forces enterprises to urgently reassess GenAI strategies, as 67% already run it in production while facing vendor lock-in and integration risks....
Is Autonomous IT the Endgame for AI in Operations or Just the Start of a Bigger Shift?
April 11, 2026

Is Autonomous IT the Endgame for AI in Operations or Just the Start of a Bigger Shift?

As Autonomous IT evolves, CIOs must weigh efficiency gains against vendor lock-in and skills gaps, raising the question: is this AI's operational endgame or just the beginning?...
Agentic AI
April 10, 2026

Oracle’s Fusion Agentic Apps: Can Platform-First AI Finally Deliver Enterprise ROI?

Oracle launches Fusion Agentic Applications with autonomous AI agents in enterprise platforms. Research shows 38.8% of enterprise buyers now expect GenAI delivery via agents, signaling a fundamental shift in how...
Can AI Save the Mainframe BMC Bets on Governance and Agentic AI
April 10, 2026

Can AI Save the Mainframe? BMC Bets on Governance and Agentic AI

Brad Shimmin and Mitch Ashley, Analysts at Futurum, examine BMC Software’s April 2026 AI expansion. The report details how uniting AMI with Control-M's new Agent Gateway addresses the mainframe demographic...

Book a Demo

Newsletter Sign-up Form

Get important insights straight to your inbox, receive first looks at eBooks, exclusive event invitations, custom content, and more. We promise not to spam you or sell your name to anyone. You can always unsubscribe at any time.

All fields are required






Thank you, we received your request, a member of our team will be in contact with you.